Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2

Journal of Clinical Investigation

Volumn 109, Issue 6, 2002, Pages 777-785

  Vajkoczy, Peter ^a   Farhadi, Mohammad ^a   Gaumann, Andreas ^b   Heidenreich, Regina ^b   Erber, Ralf ^a   Wunder, Andreas ^c   Tonn, Jörg C ^d   Mengerand, Michael D ^e   Breier, Georg ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CELL SUSPENSION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOMA; IN SITU HYBRIDIZATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR TUMOR; VASCULARIZATION;

EID: 0036200384     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214105     Document Type: Article

References (42)

1. Tumor angiogenesis: Therapeutic implications
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Tumor dormancy in vivo by prevention of neovascularization
4. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
5. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
6. Vascular-specific growth factors and blood vessel formation
7. Molecular and biological properties of vascular endothelial growth factor
8. Tie receptors: New modulators o f angiogenic and lymphangiogenic responses
9. Regulation of angiogenesis via vascular endothelial growth factor receptors
10. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
11. Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanisms
12. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
13. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
14. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
15. Glioma cell migration is associated with gliomainduced angiogenesis in vivo
16. Characterization of angiogenesis and microcirculation of highgrade glioma an intravital multifluorescence microscopic approach in the athymic nude mouse
17. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation
18. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "reflow paradox"
19. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
20. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome S define distinct subsets of nascent mesodermal cells
21. In situ hybridization with RNA probes
22. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
23. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
24. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
25. The biology of malignant gliomas-a comprehensive survey
26. C6 glioma cell invasion and migration of rat brain after neural homografting: Ultrascructure
27. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging
28. Initial stages of tumor cell-induced angiogenesis evaluation via skin window chambers in rodent models
29. Cell and environment interactions in tumor microregions: The multicell spheroid model
30. Invasion of experimental rat brain tumor: Early morphological changes following microinjection of C6 glioma cells
31. Determinants of human astrocytoma migration
32. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
33. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: A comparative study of normal and impaired repair
34. Signaling vascular morphogenesis and maintenance
35. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
36. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma
37. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
38. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis
39. Tumor endothelium specific transgene expression directed by vascular endothelial growth factor receptor (Flk-1) promoter/enhancer sequences
40. In situ expression of angiopoietins in astrocytomas identifies angiopoietin as an early marker of tumor angiogenesis
41. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
42. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases